Clinical Trials

ONITT

Link : https://www.clinicaltrials.gov/ct2/show/NCT04901702
Status : RECRUITING
Population : Recurrent/Refractory Ewing Sarcoma, Hepatoblastoma, Neuroblastoma, Osteosarcoma, Rhabdoid Tumor, Rhabdomyosarcoma, Wilms, Sarcoma
Description : Onivyde With Talazoparib or Temozolomide
PI : D. Morgenstern
Centers Opened : SickKids
Phase : I
IIST/Pharma :